Target Price | €641.00 |
Price | €380.00 |
Potential |
68.68%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Limes Schlosskliniken price target 2026.
The average Limes Schlosskliniken target price is €641.00.
This is
68.68%
register free of charge
|
|
A rating was issued by 5 analysts: 4 Analysts recommend Limes Schlosskliniken to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Limes Schlosskliniken stock has an average upside potential 2026 of
68.68%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 38.00 | 43.90 |
26.46% | 15.52% | |
EBITDA Margin | 20.21% | 24.84% |
29.79% | 22.91% | |
Net Margin | 8.95% | 11.70% |
35.98% | 30.76% |
2 Analysts have issued a sales forecast Limes Schlosskliniken 2024 . The average Limes Schlosskliniken sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Limes Schlosskliniken EBITDA forecast 2024. The average Limes Schlosskliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Limes Schlosskliniken Analysts have issued a net profit forecast 2024. The average Limes Schlosskliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | 11.72 | 17.72 |
18.27% | 51.19% | |
P/E | 21.45 | |
EV/Sales | 2.75 |
2 Analysts have issued a Limes Schlosskliniken forecast for earnings per share. The average Limes Schlosskliniken EPS is
This results in the following potential growth metrics and future valuations:
Limes Schlosskliniken...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.